{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:12:05Z","timestamp":1772881925601,"version":"3.50.1"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ministry of Science & Technology of the People's Republic of China.","award":["No. 2023YFC2509700"],"award-info":[{"award-number":["No. 2023YFC2509700"]}]},{"name":"Ministry of Science & Technology of the People's Republic of China.","award":["No. 2023YFC2509700"],"award-info":[{"award-number":["No. 2023YFC2509700"]}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science & Technology Commission.","doi-asserted-by":"crossref","award":["No. L232141"],"award-info":[{"award-number":["No. L232141"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science & Technology Commission.","doi-asserted-by":"crossref","award":["No. L232141"],"award-info":[{"award-number":["No. L232141"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science & Technology Commission","doi-asserted-by":"crossref","award":["Z221100007422019"],"award-info":[{"award-number":["Z221100007422019"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science & Technology Commission","doi-asserted-by":"crossref","award":["Z221100007422019"],"award-info":[{"award-number":["Z221100007422019"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02915-x","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T08:00:30Z","timestamp":1753257630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Modern treatment of malignant spinal cord astrocytomas: a review article"],"prefix":"10.1007","volume":"42","author":[{"given":"Xuanbo","family":"Shao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3198-0625","authenticated-orcid":false,"given":"Xiang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9100-1580","authenticated-orcid":false,"given":"Penghao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0104-115X","authenticated-orcid":false,"given":"Zan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6481-1238","authenticated-orcid":false,"given":"Zhuofan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4751-3666","authenticated-orcid":false,"given":"Wanru","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"2915_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","volume":"21","author":"QT Ostrom","year":"2019","unstructured":"Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012\u20132016. Neuro Oncol. 2019;21:v1\u2013100.","journal-title":"Neuro Oncol"},{"key":"2915_CR2","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.14245\/ns.2346650.325","volume":"20","author":"F Zhang","year":"2023","unstructured":"Zhang F, Cheng L, Ding Z, Wang S, Zhao X, Zhao Z, et al. Does H3K27M mutation impact survival outcome of high-grade spinal cord astrocytoma? Neurospine. 2023;20:1480\u20139.","journal-title":"Neurospine"},{"key":"2915_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1055\/s-0035-1549029","volume":"5","author":"D Samartzis","year":"2015","unstructured":"Samartzis D, Gillis CC, Shih P, O\u2019Toole JE, Fessler RG. Intramedullary spinal cord tumors: Part I\u2014epidemiology, pathophysiology, and diagnosis. Global spine journal. 2015;5:425\u201335.","journal-title":"Global spine journal"},{"key":"2915_CR4","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3171\/2017.1.PEDS16528","volume":"19","author":"AS Luksik","year":"2017","unstructured":"Luksik AS, Garzon-Muvdi T, Yang W, Huang J, Jallo GI. Pediatric spinal cord astrocytomas: a retrospective study of 348 patients from the SEER database. J Neurosurg Pediatr. 2017;19:711\u20139.","journal-title":"J Neurosurg Pediatr"},{"key":"2915_CR5","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00381-003-0820-3","volume":"19","author":"GI Jallo","year":"2003","unstructured":"Jallo GI, Freed D, Epstein F. Intramedullary spinal cord tumors in children. Childs Nerv Syst. 2003;19:641\u20139.","journal-title":"Childs Nerv Syst"},{"key":"2915_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3171\/jns.1992.77.3.0355","volume":"77","author":"FJ Epstein","year":"1992","unstructured":"Epstein FJ, Farmer JP, Freed D. Adult intramedullary astrocytomas of the spinal cord. J Neurosurg. 1992;77:355\u20139.","journal-title":"J Neurosurg"},{"key":"2915_CR7","doi-asserted-by":"crossref","unstructured":"Koeller KK, Rosenblum RS, Morrison AL. Neoplasms of the spinal cord and filum terminale: radiologic-pathologic correlation. Radiographics : a review publication of the Radiological Society of North America, Inc. 2000; 20: 1721\u201349.","DOI":"10.1148\/radiographics.20.6.g00nv151721"},{"key":"2915_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.neurol.2021.02.384","volume":"177","author":"C Campello","year":"2021","unstructured":"Campello C, Tabouret E, Chinot O. Challenges in diagnosis and management of adult spinal cord gliomas. Revue neurologique. 2021;177:515\u201323.","journal-title":"Revue neurologique"},{"key":"2915_CR9","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.1097\/RLU.0000000000005246","volume":"49","author":"L Morin","year":"2024","unstructured":"Morin L, Godard F, Aubriot-Lorton MH, Drouet C. Whole Spinal Cord FDG Uptake at PET\/CT Caused by H3K27-Altered Diffuse Midline Glioma in an Adult Patient. Clin Nucl Med. 2024;49:e321\u20133.","journal-title":"Clin Nucl Med"},{"key":"2915_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00401-018-1936-6","volume":"137","author":"C Pan","year":"2019","unstructured":"Pan C, Diplas BH, Chen X, Wu Y, Xiao X, Jiang L, et al. Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA. Acta Neuropathol. 2019;137:297\u2013306.","journal-title":"Acta Neuropathol"},{"key":"2915_CR11","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/neuonc\/noac280","volume":"25","author":"T Sun","year":"2023","unstructured":"Sun T, Wang Y, Liu X, Li Z, Zhang J, Lu J, et al. Deep learning based on preoperative magnetic resonance (MR) images improves the predictive power of survival models in primary spinal cord astrocytomas. Neuro Oncol. 2023;25:1157\u201365.","journal-title":"Neuro Oncol"},{"key":"2915_CR12","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/jmri.28606","volume":"58","author":"J Li","year":"2023","unstructured":"Li J, Zhang P, Qu L, Sun T, Duan Y, Wu M, et al. Deep Learning for Noninvasive Assessment of H3 K27M Mutation Status in Diffuse Midline Gliomas Using MR Imaging. J Magn Reson Imaging. 2023;58:850\u201361.","journal-title":"J Magn Reson Imaging"},{"key":"2915_CR13","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23:1231\u201351.","journal-title":"Neuro Oncol"},{"key":"2915_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jocn.2020.12.015","volume":"84","author":"W Haque","year":"2021","unstructured":"Haque W, Verma V, Barber S, Tremont IW, Brian Butler E, Teh BS. Management, outcomes, and prognostic factors of adult primary spinal cord gliomas. J Clin Neurosci. 2021;84:8\u201314.","journal-title":"J Clin Neurosci"},{"key":"2915_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3171\/2013.3.SPINE121063","volume":"19","author":"J Klekamp","year":"2013","unstructured":"Klekamp J. Treatment of intramedullary tumors: analysis of surgical morbidity and long-term results. J Neurosurg Spine. 2013;19:12\u201326.","journal-title":"J Neurosurg Spine"},{"key":"2915_CR16","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.6004\/jnccn.2017.0166","volume":"15","author":"LB Nabors","year":"2017","unstructured":"Nabors LB, Portnow J, Ammirati M, Baehring J, Brem H, Butowski N, et al. NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017. J Natl Compr Cancer Netw. 2017;15:1331\u201345.","journal-title":"J Natl Compr Cancer Netw."},{"key":"2915_CR17","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nm.4293","volume":"23","author":"F Mohammad","year":"2017","unstructured":"Mohammad F, Weissmann S, Leblanc B, Pandey DP, H\u00f8jfeldt JW, Comet I, et al. EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas. Nat Med. 2017;23:483\u201392.","journal-title":"Nat Med"},{"key":"2915_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41392-022-01274-7","volume":"8","author":"L Jing","year":"2023","unstructured":"Jing L, Qian Z, Gao Q, Sun R, Zhen Z, Wang G, et al. Diffuse midline glioma treated with epigenetic agent-based immunotherapy. Signal Transduct Target Ther. 2023;8:23.","journal-title":"Signal Transduct Target Ther"},{"key":"2915_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11060-021-03864-x","volume":"155","author":"S Akmal","year":"2021","unstructured":"Akmal S, Ginalis EE, Patel NV, Aiken R, Dicpinigaitis AJ, Hanft SJ. Leptomeningeal disease in glioblastoma: endgame or opportunity? J Neurooncol. 2021;155:107\u201315.","journal-title":"J Neurooncol"},{"key":"2915_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1328340","volume":"6","author":"K Ochs","year":"2017","unstructured":"Ochs K, Ott M, Bunse T, Sahm F, Bunse L, Deumelandt K, et al. K27M-mutant histone-3 as a novel target for glioma immunotherapy. Oncoimmunology. 2017;6: e1328340.","journal-title":"Oncoimmunology"},{"key":"2915_CR21","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131:803\u201320.","journal-title":"Acta Neuropathol"},{"key":"2915_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13153","volume":"33","author":"R-C Chai","year":"2023","unstructured":"Chai R-C, Yan H, An S-Y, Pang B, Chen H-Y, Mu Q-H, et al. Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma. Brain Pathol. 2023;33: e13153.","journal-title":"Brain Pathol"},{"key":"2915_CR23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11060-024-04584-8","volume":"166","author":"G Watanabe","year":"2024","unstructured":"Watanabe G, Wong JM, Estes B, Khan MF, Ogasawara C, Umana GE, et al. Diffuse Midline H3K27-altered gliomas in the spinal cord: a systematic review. J Neurooncol. 2024;166:379\u201394.","journal-title":"J Neurooncol"},{"key":"2915_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/21925682221094766","volume":"13","author":"M Golpayegani","year":"2022","unstructured":"Golpayegani M, Edalatfar M, Ahmadi A, Sadeghi-Naini M, Salari F, Hanaei S, et al. Complete versus incomplete surgical resection in intramedullary astrocytoma: systematic review with individual patient data meta-analysis. Global spine journal. 2022;13:227\u201341.","journal-title":"Global spine journal"},{"key":"2915_CR25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jocn.2019.02.001","volume":"63","author":"KR Hamilton","year":"2019","unstructured":"Hamilton KR, Lee SS, Urquhart JC, Jonker BP. A systematic review of outcome in intramedullary ependymoma and astrocytoma. J Clin Neurosci. 2019;63:168\u201375.","journal-title":"J Clin Neurosci"},{"key":"2915_CR26","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.spinee.2023.02.010","volume":"23","author":"EJ Chalif","year":"2023","unstructured":"Chalif EJ, Foster C, Sack K, Patrick H, Mozaffari K, Rosner M. Impact of extent of resection and adjuvant therapy in diffuse gliomas of the spine. Spine J. 2023;23:1015\u201327.","journal-title":"Spine J"},{"key":"2915_CR27","doi-asserted-by":"publisher","first-page":"6996","DOI":"10.1002\/cam4.3364","volume":"9","author":"YW Zhang","year":"2020","unstructured":"Zhang YW, Chai RC, Cao R, Jiang WJ, Liu WH, Xu YL, et al. Clinicopathological characteristics and survival of spinal cord astrocytomas. Cancer Med. 2020;9:6996\u20137006.","journal-title":"Cancer Med"},{"key":"2915_CR28","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3171\/2021.1.SPINE202017","volume":"35","author":"C Yuan","year":"2021","unstructured":"Yuan C, Yao Q, Cheng L, Zhang C, Ma L, Guan J, et al. Prognostic factors and nomogram prediction of survival probability in primary spinal cord astrocytoma patients. J Neurosurg Spine. 2021;35:651\u201362.","journal-title":"J Neurosurg Spine"},{"key":"2915_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00381-020-04722-3","volume":"37","author":"RS Nunna","year":"2021","unstructured":"Nunna RS, Khalid S, Behbahani M, Mehta AI. Pediatric primary high-grade spinal glioma: a National Cancer Database analysis of current patterns in treatment and outcomes. Child\u2019s Nerv Syst. 2021;37:185\u201393.","journal-title":"Child's Nerv Syst"},{"key":"2915_CR30","doi-asserted-by":"crossref","unstructured":"Fakhreddine MH, Mahajan A, Penas-Prado M, Weinberg J, McCutcheon IE, Puduvalli V, et al. Treatment, prognostic factors, and outcomes in spinal cord astrocytomas. 2013; 15: 406\u201312.","DOI":"10.1093\/neuonc\/nos309"},{"key":"2915_CR31","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/cncr.11514","volume":"98","author":"M Santi","year":"2003","unstructured":"Santi M, Mena H, Wong K, Koeller K, Olsen C, Rushing EJ. Spinal cord malignant astrocytomas: clinicopathologic features in 36 cases. Cancer. 2003;98:554\u201361.","journal-title":"Cancer"},{"key":"2915_CR32","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2391::AID-CNCR20>3.0.CO;2-0","volume":"83","author":"E Bouffet","year":"1998","unstructured":"Bouffet E, Pierre-Kahn A, Marchai JC, Jouvet A, Kalifa C, Choux M, et al. Prognostic factors in pediatric spinal cord astrocytoma. Cancer. 1998;83:2391\u20139.","journal-title":"Cancer"},{"key":"2915_CR33","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3171\/jns.1995.83.4.0590","volume":"83","author":"KJ Minehan","year":"1995","unstructured":"Minehan KJ, Shaw EG, Scheithauer BW, Davis DL, Onofrio BM. Spinal cord astrocytoma: pathological and treatment considerations. J Neurosurg. 1995;83:590\u20135.","journal-title":"J Neurosurg"},{"key":"2915_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/BRS.0000000000000190","volume":"39","author":"R Babu","year":"2014","unstructured":"Babu R, Karikari IO, Owens TR, Bagley CA. Spinal cord astrocytomas: a modern 20-year experience at a single institution. Spine. 2014;39:533\u201340.","journal-title":"Spine"},{"key":"2915_CR35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.nec.2019.12.004","volume":"31","author":"I Hussain","year":"2020","unstructured":"Hussain I, Parker WE, Barzilai O, Bilsky MH. Surgical management of intramedullary spinal cord tumors. Neurosurg Clin N Am. 2020;31:237\u201349.","journal-title":"Neurosurg Clin N Am"},{"key":"2915_CR36","doi-asserted-by":"publisher","first-page":"e1497","DOI":"10.1212\/WNL.0000000000206834","volume":"100","author":"A Amelot","year":"2023","unstructured":"Amelot A, Terrier LM, Mathon B, Joubert C, Picart T, Jecko V, et al. Natural course and prognosis of primary spinal glioblastoma: a nationwide study. Neurology. 2023;100:e1497\u2013509.","journal-title":"Neurology"},{"key":"2915_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.expneurol.2018.09.010","volume":"311","author":"YD Teng","year":"2019","unstructured":"Teng YD, Abd-El-Barr M, Wang L, Hajiali H, Wu L, Zafonte RD. Spinal cord astrocytomas: progresses in experimental and clinical investigations for developing recovery neurobiology-based novel therapies. Exp Neurol. 2019;311:135\u201347.","journal-title":"Exp Neurol"},{"key":"2915_CR38","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s00586-009-1076-8","volume":"18","author":"V Benes 3rd","year":"2009","unstructured":"Benes V 3rd, Barsa P, Benes V Jr, Suchomel P. Prognostic factors in intramedullary astrocytomas: a literature review. Eur Spine J. 2009;18:1397\u2013422.","journal-title":"Eur Spine J"},{"key":"2915_CR39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/noajnl\/vdad166","volume":"6","author":"J-C Tonn","year":"2024","unstructured":"Tonn J-C, Teske N, Karschnia P. Astrocytomas of the spinal cord. Neuro-oncol Adv. 2024;6:48\u201356.","journal-title":"Neuro-oncol Adv"},{"key":"2915_CR40","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3171\/2018.10.SPINE18110","volume":"30","author":"W Shi","year":"2019","unstructured":"Shi W, Wang S, Zhang H, Wang G, Guo Y, Sun Z, et al. Risk factor analysis of progressive spinal deformity after resection of intramedullary spinal cord tumors in patients who underwent laminoplasty: a report of 105 consecutive cases. J Neurosurg Spine. 2019;30:655\u201363.","journal-title":"J Neurosurg Spine"},{"key":"2915_CR41","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.3171\/2017.7.FOCUS17329","volume":"43","author":"DS Hersh","year":"2017","unstructured":"Hersh DS, Iyer RR, Garzon-Muvdi T, Liu A, Jallo GI, Groves ML. Instrumented fusion for spinal deformity after laminectomy or laminoplasty for resection of intramedullary spinal cord tumors in pediatric patients. Neurosurg Focus. 2017;43:E12.","journal-title":"Neurosurg Focus"},{"key":"2915_CR42","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3171\/2014.1.PEDS13317","volume":"13","author":"R Ahmed","year":"2014","unstructured":"Ahmed R, Menezes AH, Awe OO, Mahaney KB, Torner JC, Weinstein SL. Long-term incidence and risk factors for development of spinal deformity following resection of pediatric intramedullary spinal cord tumors. J Neurosurg Pediatr. 2014;13:613\u201321.","journal-title":"J Neurosurg Pediatr"},{"key":"2915_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11060-022-04017-4","volume":"158","author":"AM Hersh","year":"2022","unstructured":"Hersh AM, Antar A, Pennington Z, Aygun N, Patel J, Goldsborough E 3rd, et al. Predictors of survival and time to progression following operative management of intramedullary spinal cord astrocytomas. J Neurooncol. 2022;158:117\u201327.","journal-title":"J Neurooncol"},{"key":"2915_CR44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fonc.2020.00099","volume":"10","author":"D Song","year":"2020","unstructured":"Song D, Xu D, Gao Q, Hu P, Guo F. Intracranial metastases originating from pediatric primary spinal cord glioblastoma multiforme: a case report and literature review. Front Oncol. 2020;10:99.","journal-title":"Front Oncol"},{"key":"2915_CR45","doi-asserted-by":"publisher","first-page":"E21","DOI":"10.3171\/2021.2.FOCUS201084","volume":"50","author":"G Kimchi","year":"2021","unstructured":"Kimchi G, Knoller N, Korn A, Eyal-Mazuz Y, Sapir Y, Peled A, et al. Delayed variations in the diagnostic accuracy of intraoperative neuromonitoring in the resection of intramedullary spinal cord tumors. Neurosurg Focus. 2021;50:E21.","journal-title":"Neurosurg Focus"},{"key":"2915_CR46","doi-asserted-by":"publisher","first-page":"E549","DOI":"10.1093\/ons\/opab297","volume":"21","author":"C Dauleac","year":"2021","unstructured":"Dauleac C, Leroy HA, Assaker R. Minimally invasive approach for dorsal arachnoid web: 2-dimensional operative video. Oper Neurosurg. 2021;21:E549\u201350.","journal-title":"Oper Neurosurg"},{"key":"2915_CR47","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1227\/01.NEU.0000215948.97195.58","volume":"58","author":"F Sala","year":"2006","unstructured":"Sala F, Palandri G, Basso E, Lanteri P, Deletis V, Faccioli F, et al. Motor evoked potential monitoring improves outcome after surgery for intramedullary spinal cord tumors: a historical control study. Neurosurgery. 2006;58:1129\u201343.","journal-title":"Neurosurgery"},{"key":"2915_CR48","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.neucli.2022.03.004","volume":"52","author":"C Dauleac","year":"2022","unstructured":"Dauleac C, Boulogne S, Barrey CY, Guyotat J, Jouanneau E, Mertens P, et al. Predictors of functional outcome after spinal cord surgery: Relevance of intraoperative neurophysiological monitoring combined with preoperative neurophysiological and MRI assessments. Neurophysiol Clin. 2022;52:242\u201351.","journal-title":"Neurophysiol Clin"},{"key":"2915_CR49","doi-asserted-by":"crossref","unstructured":"Nabors LB, Portnow J, Ammirati M, Baehring J, Brem H, Butowski N, et al. NCCN guidelines insights: central nervous system cancers, version 1.2017. 2017; 15: 1331\u201345.","DOI":"10.6004\/jnccn.2017.0166"},{"key":"2915_CR50","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.ijrobp.2009.09.071","volume":"78","author":"RD Tendulkar","year":"2010","unstructured":"Tendulkar RD, Pai Panandiker AS, Wu S, Kun LE, Broniscer A, Sanford RA, et al. Irradiation of pediatric high-grade spinal cord tumors. Int J Radiat Oncol Biol Phys. 2010;78:1451\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2915_CR51","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/neuonc\/noz014","volume":"21","author":"R Kotecha","year":"2019","unstructured":"Kotecha R, Mehta MP, Chang EL, Brown PD, Suh JH, Lo SS, et al. Updates in the management of intradural spinal cord tumors: a radiation oncology focus. Neuro Oncol. 2019;21:707\u201318.","journal-title":"Neuro Oncol"},{"key":"2915_CR52","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/j.ijrobp.2009.04.095","volume":"76","author":"JP Kirkpatrick","year":"2010","unstructured":"Kirkpatrick JP, van der Kogel AJ, Schultheiss TE. Radiation dose-volume effects in the spinal cord. Int J Radiat Oncol Biol Phys. 2010;76:S42\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2915_CR53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0304-3835(02)00621-3","volume":"191","author":"P Sminia","year":"2003","unstructured":"Sminia P, van der Kleij AJ, Carl UM, Feldmeier JJ, Hartmann KA. Prophylactic hyperbaric oxygen treatment and rat spinal cord re-irradiation. Cancer Lett. 2003;191:59\u201365.","journal-title":"Cancer Lett"},{"key":"2915_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.07.1089","volume":"102","author":"SA Vora","year":"2018","unstructured":"Vora SA, Gondi V, Tseng YD, Vargas CE, Larson GL, Tsai HK, et al. Safety and efficacy of proton beam therapy for high-grade glioma: initial report from the proton collaborative group (PCG). Int J Radiat Oncol Biol Phys. 2018;102: e362.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2915_CR55","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.adro.2020.03.022","volume":"5","author":"AM Saeed","year":"2020","unstructured":"Saeed AM, Khairnar R, Sharma AM, Larson GL, Tsai HK, Wang CJ, et al. Clinical outcomes in patients with recurrent glioblastoma treated with proton beam therapy reirradiation: analysis of the multi-institutional proton collaborative group registry. Adv Radiat Oncol. 2020;5:978\u201383.","journal-title":"Adv Radiat Oncol"},{"key":"2915_CR56","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1093\/neuonc\/noz070","volume":"21","author":"JP Gross","year":"2019","unstructured":"Gross JP, Powell S, Zelko F, Hartsell W, Goldman S, Fangusaro J, et al. Improved neuropsychological outcomes following proton therapy relative to X-ray therapy for pediatric brain tumor patients. Neuro Oncol. 2019;21:934\u201343.","journal-title":"Neuro Oncol"},{"key":"2915_CR57","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ijrobp.2018.05.069","volume":"102","author":"MB Pulsifer","year":"2018","unstructured":"Pulsifer MB, Duncanson H, Grieco J, Evans C, Tseretopoulos ID, MacDonald S, et al. Cognitive and adaptive outcomes after proton radiation for pediatric patients with brain tumors. Int J Radiat Oncol Biol Phys. 2018;102:391\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2915_CR58","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/neuonc\/noaa182","volume":"23","author":"R Mohan","year":"2021","unstructured":"Mohan R, Liu AY, Brown PD, Mahajan A, Dinh J, Chung C, et al. Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons. Neuro Oncol. 2021;23:284\u201394.","journal-title":"Neuro Oncol"},{"key":"2915_CR59","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/j.jocn.2015.04.017","volume":"22","author":"S Hern\u00e1ndez-Dur\u00e1n","year":"2015","unstructured":"Hern\u00e1ndez-Dur\u00e1n S, Bregy A, Shah AH, Hanft S, Komotar RJ, Manzano GR. Primary spinal cord glioblastoma multiforme treated with temozolomide. J Clin Neurosci. 2015;22:1877\u201382.","journal-title":"J Clin Neurosci"},{"key":"2915_CR60","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.3171\/2014.9.FOCUS14502","volume":"37","author":"GM Barbagallo","year":"2014","unstructured":"Barbagallo GM, Paratore S, Caltabiano R, Palmucci S, Parra HS, Privitera G, et al. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles. Neurosurg Focus. 2014;37:E4.","journal-title":"Neurosurg Focus"},{"issue":"9","key":"2915_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14791\/btrt.2021.9.e8","volume":"1","author":"HI Yoon","year":"2021","unstructured":"Yoon HI, Wee CW, Kim YZ, Seo Y, Im JH, Dho YS, et al. The Korean Society for Neuro-Oncology (KSNO) Guideline for Adult Diffuse Midline Glioma: Version 20211. Brain Tumor Res Treatment. 2021;1(9):1\u20138.","journal-title":"Brain Tumor Res Treatment."},{"key":"2915_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103453","volume":"69","author":"G Price","year":"2021","unstructured":"Price G, Bouras A, Hambardzumyan D, Hadjipanayis CG. Current knowledge on the immune microenvironment and emerging immunotherapies in diffuse midline glioma. EBioMedicine. 2021;69: 103453.","journal-title":"EBioMedicine"},{"key":"2915_CR63","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/noajnl\/vdaa142","volume":"2","author":"JD Schulte","year":"2020","unstructured":"Schulte JD, Buerki RA, Lapointe S, Molinaro AM, Zhang Y, Villanueva-Meyer JE, et al. Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults. Neuro-oncol Adv. 2020;2:142.","journal-title":"Neuro-oncol Adv."},{"key":"2915_CR64","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3171\/2009.6.SPINE08910","volume":"12","author":"A Raco","year":"2010","unstructured":"Raco A, Piccirilli M, Landi A, Lenzi J, Delfini R, Cantore G. High-grade intramedullary astrocytomas: 30 years\u2019 experience at the Neurosurgery Department of the University of Rome \u201cSapienza.\u201d J Neurosurg Spine. 2010;12:144\u201353.","journal-title":"J Neurosurg Spine"},{"key":"2915_CR65","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006634","volume":"96","author":"CX Shen","year":"2017","unstructured":"Shen CX, Wu JF, Zhao W, Cai ZW, Cai RZ, Chen CM. Primary spinal glioblastoma multiforme: a case report and review of the literature. Medicine. 2017;96: e6634.","journal-title":"Medicine"},{"key":"2915_CR66","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-020-00937-8","volume":"13","author":"R Duan","year":"2020","unstructured":"Duan R, Du W, Guo W. EZH2: a novel target for cancer treatment. J Hematol Oncol. 2020;13:104.","journal-title":"J Hematol Oncol"},{"key":"2915_CR67","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1055\/s-0042-105292","volume":"228","author":"M Wiese","year":"2016","unstructured":"Wiese M, Schill F, Sturm D, Pfister S, Hulleman E, Johnsen SA, et al. No Significant Cytotoxic Effect of the EZH2 Inhibitor Tazemetostat (EPZ-6438) on Pediatric Glioma Cells with Wildtype Histone 3 or Mutated Histone 33. Klin Padiatr. 2016;228:113\u20137.","journal-title":"Klin Padiatr"},{"key":"2915_CR68","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40478-022-01336-5","volume":"10","author":"S Dhar","year":"2022","unstructured":"Dhar S, Gadd S, Patel P, Vaynshteyn J, Raju GP, Hashizume R, et al. A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis. Acta Neuropathol Commun. 2022;10:47.","journal-title":"Acta Neuropathol Commun"},{"key":"2915_CR69","doi-asserted-by":"publisher","first-page":"12460","DOI":"10.1021\/acs.jmedchem.0c00830","volume":"63","author":"TCS Ho","year":"2020","unstructured":"Ho TCS, Chan AHY, Ganesan A. Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight. J Med Chem. 2020;63:12460\u201384.","journal-title":"J Med Chem"},{"key":"2915_CR70","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1172\/JCI69738","volume":"124","author":"AC West","year":"2014","unstructured":"West AC, Johnstone RW. New and emerging HDAC inhibitors for cancer treatment. J Clin Invest. 2014;124:30\u20139.","journal-title":"J Clin Invest"},{"key":"2915_CR71","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11912-020-0877-0","volume":"22","author":"K Wierzbicki","year":"2020","unstructured":"Wierzbicki K, Ravi K, Franson A, Bruzek A, Cantor E, Harris M, et al. Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma. Curr Oncol Rep. 2020;22:19.","journal-title":"Curr Oncol Rep"},{"key":"2915_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169485","volume":"12","author":"T Hennika","year":"2017","unstructured":"Hennika T, Hu G, Olaciregui NG, Barton KL, Ehteda A, Chitranjan A, et al. Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models. PLoS ONE. 2017;12: e0169485.","journal-title":"PLoS ONE"},{"key":"2915_CR73","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11060-022-03950-8","volume":"157","author":"BJ Neth","year":"2022","unstructured":"Neth BJ, Balakrishnan SN, Carabenciov ID, Uhm JH, Daniels DJ, Kizilbash SH, et al. Panobinostat in adults with H3 K27M-mutant diffuse midline glioma: a single-center experience. J Neurooncol. 2022;157:91\u2013100.","journal-title":"J Neurooncol"},{"key":"2915_CR74","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ccell.2019.03.014","volume":"35","author":"J Ishizawa","year":"2019","unstructured":"Ishizawa J, Zarabi SF, Davis RE, Halgas O, Nii T, Jitkova Y, et al. Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality. Cancer Cell. 2019;35:721-37.e9.","journal-title":"Cancer Cell"},{"key":"2915_CR75","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.neo.2020.09.005","volume":"22","author":"VV Prabhu","year":"2020","unstructured":"Prabhu VV, Morrow S, Rahman Kawakibi A, Zhou L, Ralff M, Ray J, et al. ONC201 and imipridones: anti-cancer compounds with clinical efficacy. Neoplasia (New York, NY). 2020;22:725\u201344.","journal-title":"Neoplasia (New York, NY)"},{"key":"2915_CR76","doi-asserted-by":"publisher","first-page":"17117","DOI":"10.1126\/scitranslmed.3004828","volume":"5","author":"JE Allen","year":"2013","unstructured":"Allen JE, Krigsfeld G, Mayes PA, Patel L, Dicker DT, Patel AS, et al. Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects. Sci Transl Med. 2013;5:17117.","journal-title":"Sci Transl Med."},{"key":"2915_CR77","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1126\/scisignal.aac4374","volume":"9","author":"CL Kline","year":"2016","unstructured":"Kline CL, Van den Heuvel AP, Allen JE, Prabhu VV, Dicker DT, El-Deiry WS. ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2\u03b1 kinases. Sci Signal. 2016;9:18.","journal-title":"Sci Signal."},{"key":"2915_CR78","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11060-019-03271-3","volume":"145","author":"AS Chi","year":"2019","unstructured":"Chi AS, Tarapore RS, Hall MD, Shonka N, Gardner S, Umemura Y, et al. Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201. J Neurooncol. 2019;145:97\u2013105.","journal-title":"J Neurooncol"},{"key":"2915_CR79","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41591-018-0337-7","volume":"25","author":"TF Cloughesy","year":"2019","unstructured":"Cloughesy TF, Mochizuki AY, Orpilla JR, Hugo W, Lee AH, Davidson TB, et al. Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Nat Med. 2019;25:477\u201386.","journal-title":"Nat Med"},{"key":"2915_CR80","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11060-015-1769-2","volume":"123","author":"JA Ellis","year":"2015","unstructured":"Ellis JA, Castelli M, Assanah M, Bruce JN, Canoll P, Ogden AT. Unique microenvironmental responses to PDGF stimulation in brain and spinal cord gliomas determine tumor phenotype. J Neurooncol. 2015;123:27\u201333.","journal-title":"J Neurooncol"},{"key":"2915_CR81","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/neup.12594","volume":"39","author":"P Jha","year":"2019","unstructured":"Jha P, Manjunath N, Singh J, Mani K, Garg A, Kaur K, et al. Analysis of PD-L1 expression and T cell infiltration in different molecular subgroups of diffuse midline gliomas. Neuropathology. 2019;39:413\u201324.","journal-title":"Neuropathology"},{"key":"2915_CR82","doi-asserted-by":"crossref","unstructured":"Gasanz Garicochea M, Mart\u00ednez-Romera I, Osuna-Marco MP, L\u00f3pez-Ibor Ali\u00f1o B. Clinical experience with immunotherapy in patients with diffuse intrinsic pontine glioma. Eur J Hosp Pharm. 2023.","DOI":"10.1136\/ejhpharm-2022-003511"},{"key":"2915_CR83","doi-asserted-by":"crossref","unstructured":"Eshhar Z. The T-body approach: redirecting T cells with antibody specificity. Handbook of experimental pharmacology. 2008: 329\u201342.","DOI":"10.1007\/978-3-540-73259-4_14"},{"key":"2915_CR84","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/jgm.2604","volume":"14","author":"KJ Curran","year":"2012","unstructured":"Curran KJ, Pegram HJ, Brentjens RJ. Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions. J Gene Med. 2012;14:405\u201315.","journal-title":"J Gene Med"},{"key":"2915_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/djv439","volume":"108","author":"H Dai","year":"2016","unstructured":"Dai H, Wang Y, Lu X, Han W. Chimeric antigen receptors modified t-cells for cancer therapy. J Natl Cancer Inst. 2016;108:1.","journal-title":"J Natl Cancer Inst"},{"key":"2915_CR86","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13045-017-0423-1","volume":"10","author":"Z Wang","year":"2017","unstructured":"Wang Z, Wu Z, Liu Y, Han W. New development in CAR-T cell therapy. J Hematol Oncol. 2017;10:53.","journal-title":"J Hematol Oncol"},{"key":"2915_CR87","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41551-018-0235-9","volume":"2","author":"L Labanieh","year":"2018","unstructured":"Labanieh L, Majzner RG, Mackall CL. Programming CAR-T cells to kill cancer. Nature Biomedical Engineering. 2018;2:377\u201391.","journal-title":"Nature Biomedical Engineering"},{"key":"2915_CR88","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41586-024-08171-9","volume":"637","author":"M Monje","year":"2025","unstructured":"Monje M, Mahdi J, Majzner R, Yeom KW, Schultz LM, Richards RM, et al. Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas. Nature. 2025;637:708\u201315.","journal-title":"Nature"},{"key":"2915_CR89","doi-asserted-by":"crossref","unstructured":"Chheda ZS, Kohanbash G, Okada K, Jahan N, Sidney J, Pecoraro M, et al. Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy. J Exp Med. 2018; 215: 141\u201357.","DOI":"10.1084\/jem.20171046"},{"key":"2915_CR90","doi-asserted-by":"crossref","unstructured":"Mueller S, Taitt JM, Villanueva-Meyer JE, Bonner ER, Nejo T, Lulla RR, et al. Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma. J Clin Invest. 2020; 130: 6325\u201337.","DOI":"10.1172\/JCI140378"},{"key":"2915_CR91","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-021-03363-z","volume":"592","author":"M Platten","year":"2021","unstructured":"Platten M, Bunse L, Wick A, Bunse T, Le Cornet L, Harting I, et al. A vaccine targeting mutant IDH1 in newly diagnosed glioma. Nature. 2021;592:463\u20138.","journal-title":"Nature"},{"key":"2915_CR92","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14563","volume":"30","author":"A Yu","year":"2024","unstructured":"Yu A, Zeng J, Yu J, Cao S, Li A. Theory and application of TTFields in newly diagnosed glioblastoma. CNS Neurosci Ther. 2024;30: e14563.","journal-title":"CNS Neurosci Ther"},{"key":"2915_CR93","volume":"15","author":"EK Mikobi","year":"2023","unstructured":"Mikobi EK, Voorhees G, Mahmood A, Gandhi A, Bailey M, Phillips J. Influence of tumor-treating fields in a young patient with primary spinal glioblastoma multiforme (GBM): a case report of a rare tumor. Cureus. 2023;15: e49441.","journal-title":"Cureus"},{"key":"2915_CR94","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s00381-022-05465-z","volume":"38","author":"H G\u00f6tt","year":"2022","unstructured":"G\u00f6tt H, Kiez S, Dohmen H, Kolodziej M, Stein M. Tumor treating fields therapy is feasible and safe in a 3-year-old patient with diffuse midline glioma H3K27M - a case report. Child\u2019s Nerv Syst. 2022;38:1791\u20136.","journal-title":"Child's Nerv Syst"},{"key":"2915_CR95","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S1470-2045(21)00578-7","volume":"23","author":"PY Wen","year":"2022","unstructured":"Wen PY, Stein A, van den Bent M, De Greve J, Wick A, de Vos F, et al. Dabrafenib plus trametinib in patients with BRAF(V600E)-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial. Lancet Oncol. 2022;23:53\u201364.","journal-title":"Lancet Oncol"},{"key":"2915_CR96","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3171\/spi.2007.6.5.447","volume":"6","author":"RA Rovin","year":"2007","unstructured":"Rovin RA, Winn R. Expression of O6-methylguanine-deoxyribose nucleic acid methyltransferase and temozolomide response in a patient with a malignant spinal cord astrocytoma. Case Rep J Neurosurg Spine. 2007;6:447\u201350.","journal-title":"Case Rep J Neurosurg Spine"},{"key":"2915_CR97","doi-asserted-by":"crossref","unstructured":"Wu J, Zhou Z, Wu Z, Tang Z, Li M, Yin S, et al. Consensus of Chinese experts on glioma multidisciplinary team management (2nd edition). Chin Med J. 2024; 137: 1267\u201370.","DOI":"10.1097\/CM9.0000000000003129"},{"issue":"156","key":"2915_CR98","first-page":"329","volume":"2006","author":"W Grisold","year":"1946","unstructured":"Grisold W, Oberndorfer S, Hitzenberger P. Editorial: brain tumour treatment: the concept of inter- and multidisciplinary treatment. Wien Med Wochenschr. 1946;2006(156):329\u201331.","journal-title":"Wien Med Wochenschr"},{"key":"2915_CR99","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/path.6084","volume":"260","author":"L Cheng","year":"2023","unstructured":"Cheng L, Zhang F, Zhao X, Wang L, Duan W, Guan J, et al. Mutational landscape of primary spinal cord astrocytoma. J Pathol. 2023;260:317\u201328.","journal-title":"J Pathol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02915-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02915-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02915-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T21:13:25Z","timestamp":1757279605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02915-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":99,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["2915"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02915-x","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval is not required because of the review nature of the research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"369"}}